stonks4u
Sign up free
CVSI logo

CVSI CV Sciences, Inc.

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$0.03
+0.00 (+18.34%)

CV Sciences, Inc. functions as a life sciences organization primarily operating across North America. Its business activities are organized into two distinct divisions: Consumer Products and Specialty Pharmaceutical. The Consumer Products division focuses on the creation, manufacturing, and commercialization of plant-derived dietary supplements and cannabidiol (CBD) products sourced from hemp. The…

Market Cap: $6.12Mwww.cvsciences.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
8093107120
Aug 10Aug 13

Quote

Day Range
$0.02 – $0.03
52-Week Range
$0.02 – $0.10
Volume
$61.5K
Market Cap
$6.12M
50-Day Avg
$0.02
200-Day Avg
$0.04
Prev Close
$0.03
Open
$0.03

Valuation & Ratios

P/E Ratio
-11.81
EPS
$-0.01
P/B Ratio
7.71
P/S Ratio
0.82
Debt/Equity
1.10
Current Ratio
1.03
Dividend Yield
+0.0%
Gross Margin
+49.0%

Returns & Efficiency

Return on Equity
-65.3%
Return on Assets
-13.8%
FCF Yield
-4.6%
EV/EBITDA
-22.50

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$13.79M$-958.0K$-0.01
2024$15.71M$-2.39M$-0.01
2023$16.00M$3.10M$0.02
2022$16.20M$-8.21M$-0.06
2021$20.05M$-15.55M$-0.14

Social Signal Score

44
5d
45
3 mentions
—
30d
44
3 mentions
—
60d
44
3 mentions
—
90d
44
3 mentions
—
news: 3

Earnings

Mon, Nov 16(in 3 months)

Consensus estimate $-0.03 per share

3of 3 quarters beat consensus

Typical surprise +83.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 13$-0.00 vs $-0.02beat
  • Thu, May 14$-0.00 vs $-0.02beat
  • Thu, Mar 26$-0.00 vs $-0.01beat

Estimates and results for CVSI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

CVSIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (3)

  • Newsseekingalpha.com·1d ago·Positive

    CV Sciences, Inc. (CVSI) Q2 2026 Earnings Call Transcript CV Sciences, Inc. (CVSI) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newsaccessnewswire.com·3d ago·Negative

    CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids New digital destination brings the Company's Health Intelligence approach to life, helping consumers better understand their needs, discover science-backed solutions, and navigate healthy aging. SAN DIEGO, CA / ACCESS Newswire / August 11, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "our", "us" or "we"), a consumer health company specializing in science-backed natural ingredients and products, today

    View source ↗
  • Newsaccessnewswire.com·4d ago·Negative

    CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026 SAN DIEGO, CA / ACCESS Newswire / August 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the second quarter ended June 30, 2026, after the stock market closes on Thursday, August 13

    View source ↗